Cellular immunity, also known as cell-mediated immunity, is a vital component of the immune system responsible for defending the body against intracellular pathogens, abnormal cells, and various threats. Key players in cellular immunity are T lymphocytes (T cells), which are crucial for orchestrating and executing immune responses. Cellular immunity involves the recognition of antigens presented by infected or abnormal cells. Antigen-presenting cells, such as macrophages and dendritic cells, process and present antigens to T cells. This interaction activates cytotoxic T cells, which directly attack and destroy infected or abnormal cells. Helper T cells play a regulatory role by coordinating immune responses and enhancing the activity of other immune cells. Major histocompatibility complex (MHC) molecules facilitate the presentation of antigens to T cells, ensuring specificity in the immune response. Cytokines, signaling proteins released by immune cells, modulate cellular immunity, influencing the activation, proliferation, and function of T cells. Cellular immunity is crucial for eliminating viruses, intracellular bacteria, and cancer cells. Dysfunction in cellular immunity can lead to increased susceptibility to infections and the development of certain cancers. Understanding cellular immunity is essential for vaccine development, immunotherapy, and managing various immune-related disorders.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia